USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Abb Vie Deutschland Gmbh & Co. KG

USPTO PatentsView assignee record - 126 granted patents across 25 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company

The verdict

According to USPTO PatentsView, Abb ranks #3,004 of 49,997 tracked US assignees by granted-patent volume, with 126 patents across 25 technology areas.

#3,004
of 49,997 US assignees by volume
Top 13%
by Innovation Score (50.4/100)
21.0
avg claims per patent
-89%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3004 · Foreign Corporation #3,004 · 126 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MID 126 grants
  • TOP-DECILE #3,004/49,997
  • PHOTO-FINISH Ceres
  • CPC-FOCUS A61P · 25 areas
  • INNOV-PAR 50.4/100
  • CLAIMS-DENSE 21.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -89% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ceres, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Abb

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Abb's Innovation Score is 50.4/100 (top 13% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Abb's grants concentrate

Abb Vie Deutschland Gmbh & Co. KG is a focused PatentsView assignee: 25 CPC subclasses with 82.5% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (35 grants) versus a trough of 2 in 2024. By volume, Abb sits between W. Kordes' SÖHNE Rosenschulen GmbH & Co KG and Dexin Corporation.

Abb's three-year grant acceleration

Abb Vie Deutschland Gmbh & Co. KG shows 6 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Abb's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Abb holds 126 patents at rank #3,004, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Abb

By rank, the assignees closest to #3,004 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Abb's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Abb, neither rank-band nor same-CPC leaders (those blocks stay above).

Abb's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 13% higher than 87% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

010203040 201520162017201820192020202220242025 2
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Abb Vie Deutschland Gmbh & Co. KG patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 35 27.8%
2016 32 25.4%
2017 24 19.0%
2018 15 11.9%
2019 6 4.8%
2020 6 4.8%
2022 4 3.2%
2024 2 1.6%
2025partial year 2 1.6%

Which technologies does Abb Vie Deutschland Gmbh & Co. KG patent most?

Top 15 of 25 technology areas

Where it ranks

Overall rank by patents

#3,004

of 49,997 tracked assignees

Innovation Score

50.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Abb Vie Deutschland Gmbh & Co. KG's patent record in context - here's where to go next.

  • Abb Vie Deutschland Gmbh & Co. KG's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 82.5% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #3,004 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Abb Vie Deutschland Gmbh & Co. KG against W. Kordes' SÖHNE Rosenschulen GmbH & Co KG, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 50.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.